KRT7 and bladder adenocarcinoma: Torenbeek et al.4 observed the expression, at least focally, of CK7 in 82% of cases and CK20 in 73%, whereas a CK20-positive and CK7-negative profile was detected in only 29% of the cases of primary adenocarcinomas of the bladder.3